Resultado da Busca
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).
12 de jun. de 2023 · Former CEO and executive chairman of Merck, Ken Frazier, offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.
4 de fev. de 2021 · Merck CEO Kenneth Frazier, who is currently one of the few Black CEOs of a Fortune 500 company, is retiring in June, ending a nearly 30-year run with the company.
4 de fev. de 2021 · Merck & Co's chief executive Kenneth Frazier is retiring at the end of June, the drugs company said. The firm said he would be replaced by current chief financial officer Robert Davis, who...
4 de fev. de 2021 · Merck's outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday.
4 de fev. de 2021 · KENILWORTH, N.J., Feb. 4, 2021 – MSD (NYSE:MRK), a trade name of Merck & Co., Inc, Kenilworth, NJ, USA, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.
4 de fev. de 2021 · Merck’s outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday. Frazier, 66, will be succeeded on June 30 by CFO Robert...
